Ma Xiang-Juan, Ren Han-Yun, Qiu Zhi-Xiang, Cen Xi-Nan, Ou Jin-Ping, Wang Wen-Sheng, Xu Wei-Lin, Wang Li-Hong, Dong Yu-Jun, Sun Yu-Hua, Li Yuan, Yin Yue
Department of Hematology, Peking University First Hospital, Beijing 10034, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Aug;18(4):1007-12.
The aim of this study was to analyze the risk factors of hemorrhagic cystitis (HC) after hematopoietic stem cell transplantation (HSCT). The data of 188 transplant patients treated from July 2003 to August 2009 in Peking University First Hospital were studied. The patients were followed up to 180 days after HSCT. Clinical records of the total 188 cases and the 150 cases underwent allogeneic HSCT out of 188 cases were analyzed by using a Cox regression model respectively. The results indicated as follows: (1) 51 of 188 patients developed HC (27.12%). Univariate analysis showed that sex (male RR = 1.673, p = 0.076), allogeneic HSCT (RR = 1.848, p = 0.061) were related to HC, and allogeneic HSCT (RR = 4.508, p = 0.037) was the independent risk factor for HC by multivariate analysis. (2) HC occurred in 32.67% (49/150) patients who underwent allogeneic HSCT, with 42 cases of grade II-IV HC (28.00%). For the incidence of grade II-IV HC, univariate analysis revealed mismatched related donor/matched unrelated donor (RR 2.444, p = 0.018), CMV viruria (RR 2.059, p = 0.021) and CMV positive in serum and urine at the same time (RR 2.497, p = 0.003) were risk factors. The following factors, as conditioning with Fludarabine (Flu) (RR 0.504, p = 0.059) and TBI (RR 0.185, p = 0.095), were associated with a decreased tendency of II-IV HC at age of 26 - 40 (compared with age ≤ 25 or ≥ 41, RR 0.454, p = 0.056). Some others, as conditioning with CTX (RR2.015, p = 0.063), the application of ATG (RR 2.343, p = 0.054) and CMV viremia (RR 2.123, p = 0.088), were associated with an increased tendency of II-IV HC by univariate analysis. Multivariate analysis demonstrated that CMV positive in serum and urine at the same time (RR 2.269, p = 0.008), conditioning without Flu (RR = 2.106, p = 0.040) were the independent risk factor for grade II-IV HC. And the application of ATG (RR = 2.154, p = 0.083) was related to the tendency of higher incidence of grade II-IV HC. It is concluded that the incidence of HC is high in patients underwent allogeneic HSCT. CMV positive in serum and urine at the same time, while conditioning without Flu are the independent risk factors of grade II-IV HC. Application of ATG is related to the increased trend of grade II-IV HC.
本研究旨在分析造血干细胞移植(HSCT)后出血性膀胱炎(HC)的危险因素。对2003年7月至2009年8月在北京大学第一医院接受治疗的188例移植患者的数据进行了研究。对患者进行HSCT后长达180天的随访。分别采用Cox回归模型对188例患者的全部临床记录以及188例中接受异基因HSCT的150例患者的临床记录进行分析。结果如下:(1)188例患者中有51例发生HC(27.12%)。单因素分析显示,性别(男性RR = 1.673,p = 0.076)、异基因HSCT(RR = 1.848,p = 0.061)与HC相关,多因素分析显示异基因HSCT(RR = 4.508,p = 0.037)是HC的独立危险因素。(2)接受异基因HSCT的患者中32.67%(49/150)发生HC,其中42例为II - IV级HC(28.00%)。对于II - IV级HC的发生率,单因素分析显示,人类白细胞抗原不相合的亲属供者/人类白细胞抗原相合的非亲属供者(RR 2.444,p = 0.018)、巨细胞病毒(CMV)病毒尿(RR 2.059,p = 0.021)以及血清和尿液同时CMV阳性(RR 2.497,p = 0.003)是危险因素。以下因素,如使用氟达拉滨(Flu)进行预处理(RR 0.504,p = 0.059)和全身照射(TBI)(RR 0.185,p = 0.095),与26 - 40岁时II - IV级HC发生率降低的趋势相关(与年龄≤25岁或≥41岁相比,RR 0.454,p = 0.056)。其他一些因素,如使用环磷酰胺(CTX)进行预处理(RR2.015,p = 0.063)、应用抗胸腺细胞球蛋白(ATG)(RR 2.343,p = 0.054)以及CMV病毒血症(RR 2.123,p = 0.088),单因素分析显示与II - IV级HC发生率增加的趋势相关。多因素分析表明,血清和尿液同时CMV阳性(RR 2.269,p = 0.008)、未使用Flu进行预处理(RR = 2.106,p = 0.040)是II - IV级HC的独立危险因素。并且应用ATG(RR = 2.154,p = 0.083)与II - IV级HC发生率较高的趋势相关。结论是接受异基因HSCT的患者中HC发生率较高。血清和尿液同时CMV阳性以及未使用Flu进行预处理是II - IV级HC的独立危险因素。应用ATG与II - IV级HC发生率增加的趋势相关。